Company intelligence / Profile preview

Baird

Ownership: Private
Development stage: Other

Overview

Baird Medical leads China’s market in microwave ablation devices for thyroid nodules. Its technology offers a minimally invasive alternative to surgery with faster recovery and less scarring. The company has expanded globally, including deployments at major U.S. hospitals such as Johns Hopkins Hospital and Weill Cornell Medicine. It continues to innovate with AI-driven surgical robotics and maintains strong academic collaborations.

Therapeutic areas: EndocrinologyOncologyOther
Modalities: Device (Microwave ablation system)AI-powered surgical robotic systems
Industry: Therapeutic Medical Devices

Partnerships

Collaborations with leading healthcare institutions/hospitals worldwide—including Johns Hopkins Hospital, Tulane Medical Center, Weill Cornell Medicine, Columbia University Medical Center—and distribution/training partnerships across >20 countries

Beyond the preview

Go deeper on Baird.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baird.

Explore the full profile